Lead research scientist from UNC’s Cohen lab, Jui-Heng Tseng, PhD, was recently awarded $175,000 from the Alzheimer’s Association for his research project, “Unraveling new signaling pathways for tau-mediated neurodegeneration.”
Send us your news to share with the Duke-UNC Alzheimer’s disease research community!
Save the date for SLAM-DUNC!
June 24-25, 2022, Karsh Alumni and Visitors Center, Duke University
The first Symposium for Learning about Alzheimer’s disease-related Medical research at Duke and UNC (SLAM-DUNC) will be held Friday-Saturday, June 24 – 25 at the Duke Karsh Alumni and Visitors Center. The symposium is open to researchers, clinicians, and trainees from Duke, UNC, NCCU, UNC-Pembroke, and ECU and will include:
- Research presentations from REC Scholars and trainees
- A poster session
- Networking sessions
- Information about ADRC core resources
A call for abstracts will be sent out in the coming weeks. We look forward to seeing you there!
Mechanisms of Brain Hypoperfusion in AD/ADRD
The National Institute on Aging recently published a new funding opportunity announcement (FOA) on the ‘Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed).’ This FOA aims to understand molecular and cellular mechanisms underlying cerebral blood flow reduction in Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). The FOA solicits human subject and animal research across a broad range of topics and laboratory models.
While this FOA is primarily intended to understand mechanisms of cerebrovascular dysfunctions in AD/ADRD, applications on cerebrovascular pathologies that occur in the absence of these diseases are responsive to the FOA, if these pathologies can be mechanistically link to AD and/or ADRD.